{"data":{"id":"us/21-cfr-369.3","jurisdiction":"us","citation":"21 CFR 369.3","heading":"Warnings required on drugs exempted from prescription-dispensing requirements of section 503(b)(1)(C).","body":"Drugs exempted from prescription-dispensing requirements under section 503(b)(1)(C) of the act are subject to the labeling requirements prescribed in § 310.201(a) of this chapter. Although, for convenience, warning and caution statements for a number of the drugs named in § 310.201 of this chapter (cross-referenced in the text of this part) are included in subpart B of this part, the inclusion of such drugs in §§ 369.20 or 369.21 in no way affects the requirements for compliance with § 310.201(a) of this chapter, or the provisions of an effective application pursuant to section 505(b) of the act.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 369—INTERPRETATIVE STATEMENTS RE WARNINGS ON DRUGS AND DEVICES FOR OVER-THE-COUNTER SALE","Subpart A—Definitions and Interpretations"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"a55b21963f35ab59828f0a9b8d7c407017a37e0b172b3e801b158fea16076ac1","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-369.2","next":"us/21-cfr-369.4"},"notice":"GroundRules: Original legal text. Not legal advice."}